170553 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
Crown Rot Resistance
#2METHODS OF EVALUATING TREATMENT OUTCOME IN HIGH GRADE SEROUS OVARIAN CANCER
#3BIOSENSOR FOR TRIGLYCERIDES
#4PROCESS FOR HIGH PERFORMANCE BARCODED MAGNETIC BEADS
#5SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#6PYRUVATE SENSOR AND RELATED METHOD
#7Method For Fractionation Of Biomolecules
#8ISOTOPICALLY MODIFIED COMPONENTS AND THERAPEUTIC USES THEREOF
#9Compound and a method for identifying a protein using said compound
#10BIOMARKERS FOR RADIATION TREATMENT
#11METHODS AND DEVICES FOR DETECTING BIOMARKERS ASSOCIATED WITH PREECLAMPSIA
#12Tumor blood marker, use thereof, and kit comprising the same
#13FLUORESCENT PROBE FOR ALDH3A1 DETECTION
#14SYSTEM AND METHOD FOR DETECTING NEURAL INJURY
#15Isotopically modified components and therapeutic uses thereof
#16Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss
#17Methods and compositions for identifying leukemic stem cells
#18ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS
#19METHODS AND DEVICES FOR DETECTING METHANOL POISONING USING FORMATE OXIDASE
#20Biomarkers for radiation treatment
#21Methods for determining the metabolic status of lymphomas
#22METHOD FOR IMPROVED HEPATOCELLULAR CANCER DIAGNOSIS
#23Methods and compositions for identifying leukemic stem cells
#24Measuring GAPDH protein for diagnosis and treatment of alzheimer's disease
#25Lateral flow device and method of use
#26Systems and methods for electrochemical triglycerides assays
#27Identification of cancer stem cells markers and use of same for diagnosis and treatment
#28System and method for detecting neural injury
#29Method for predicting the responsiveness a patient to a treatment with an anti-CD20 antibody
#30Breast Cancer Biomarker
#31PEPTIDOMIMETIC COMPOUNDS AND RELATED METHODS
#32STROMA BIOMARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER
#33METHODS OF TREATING NEUROLOGICAL AUTOIMMUNE DISORDERS WITH CYCLOPHOSPHAMIDE
#34Biomarkers for radiation treatment
#35RADIOACTIVE SUBSTRATES FOR ALDEHYDE DEHYDROGENASE
#36METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#37Treatment of drug abuse by preventing GAPDH nitrosylation
#38SYSTEMS AND METHODS FOR MONITORING BIOLOGICAL FLUIDS
#39PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON HYPOXIC STATUS
#40E1 ENZYME MUTANTS AND USES THEREOF
#41Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide
#42Methods for detecting and monitoring circulating cancer stem cells
#43Aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker
#44Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs)
#45Method of detecting metastasizing cancer cells originating in stomach cancer
#46ALDH1 As A Cancer Stem Cell Marker
#47Tissue diagnostics for ovarian cancer
#48Glyceraldehyde 3-phosphate dehydrogenase-S (GAPDHS), a glycolytic anzyme expressed only in male germ cells, is a target for male contraception